Fig. 1From: Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similarH&E stain and all immunohistochemical stainings of a PT (a) H&E (b) CD3 (c) CD4 (d) CD8 (e) CD56Back to article page